Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$30.58 -0.17 (-0.55%)
At close: Oct 21, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) Current Deferred Revenue (2013 - 2026)

Updated

Lakefront Biotherapeutics (LKFT) reported Current Deferred Revenue of $37,464 for the quarter ended Mar 31, 2026, down 100.0% from $242.6 million a year earlier but up 0.6% from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Current Deferred Revenue (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, Lakefront Biotherapeutics posted Current Deferred Revenue of $36,154, down 100.0% from the prior year.

  • Current Deferred Revenue has declined for five consecutive years, with a five-year compound annual growth rate of -96.3% (years ended Dec 2020 to Dec 2025).
  • By year, Current Deferred Revenue came in at $251.62 million in the year ended Dec 31, 2024 (-8.7%), $275.73 million in the year ended Dec 31, 2023 (-99.9%), $385.36 billion in the year ended Dec 31, 2022 (-22.4%) and $496.87 billion in the year ended Dec 31, 2021 (-1.8%).
  • Five-year quarterly Current Deferred Revenue spans a low of $37,249 in the quarter ended Dec 31, 2025 and a high of $480.31 billion in the quarter ended Dec 31, 2021.
  • Year over year, Current Deferred Revenue gained in 1 of the last six quarters, with an average decline of 39.0%.
  • The high point for year-over-year Current Deferred Revenue in five years was the quarter ended Jun 30, 2021 (growth of 13.2%); the low point was the quarter ended Dec 31, 2025 (a decline of 100.0%).
  • Per Business Quant data, the three quarters before the quarter ended Mar 31, 2026 came in at $37,249 (quarter ended Dec 31, 2025), $269.02 million (quarter ended Sep 30, 2025) and $260.62 million (quarter ended Jun 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Lakefront Biotherapeutics 2.01 Bn 2.01 Bn 3.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 36,672.01
Dec 31, 2025 37,591.34
Sep 30, 2025 269.97 Mn
Jun 30, 2025 270.01 Mn
Mar 31, 2025 249.64 Mn
Dec 31, 2024 241.92 Mn
Sep 30, 2024 257.95 Mn
Mar 31, 2024 250.93 Mn
Dec 31, 2023 283.64 Mn
Sep 30, 2023 333.21 Mn
Mar 31, 2023 383.10 Mn
Dec 31, 2022 389.79 Bn
Mar 31, 2022 466.70 Mn
Dec 31, 2021 475.50 Bn
Jun 30, 2021 3.05 Bn
Dec 31, 2020 3.46 Bn
Jun 30, 2020 3.18 Bn
Mar 31, 2020 462.25 Mn
Dec 31, 2019 3.36 Bn
Sep 30, 2019 512.96 Mn
API Access

Lakefront Biotherapeutics Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=LKFT&period=max&api_key=YOUR_API_KEY